Immediate Impact
49 standout
Citing Papers
The hallmarks of cancer immune evasion
2024 Standout
Targeting ROS in cancer: rationale and strategies
2024 Standout
Works of Ellen Ingalla being referenced
Expression Profile of BCL-2, BCL-XL, and MCL-1 Predicts Pharmacological Response to the BCL-2 Selective Antagonist Venetoclax in Multiple Myeloma Models
2016
Author Peers
| Author | Last Decade | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|
| Ellen Ingalla | 237 | 17 | 23 | 126 | 124 | 11 | 332 | |
| Jason C. Paik | 208 | 26 | 17 | 62 | 143 | 16 | 369 | |
| Connie Qi | 231 | 12 | 20 | 264 | 135 | 14 | 345 | |
| Luke B. Fletcher | 165 | 14 | 39 | 116 | 63 | 16 | 319 | |
| Kenneth Anderson | 116 | 6 | 10 | 127 | 73 | 12 | 265 | |
| Philip R. Greipp | 161 | 24 | 15 | 198 | 116 | 8 | 320 | |
| Bettina Wingelhofer | 198 | 12 | 16 | 73 | 121 | 12 | 365 | |
| Even H. Rustad | 153 | 5 | 10 | 207 | 143 | 13 | 298 | |
| Guilhem Couderc | 197 | 26 | 8 | 141 | 140 | 9 | 364 | |
| Irene Manrique | 202 | 5 | 27 | 144 | 194 | 14 | 371 | |
| Jacob Haaber | 104 | 17 | 31 | 85 | 188 | 13 | 326 |
All Works
Login with ORCID to disown or claim papers
Loading papers...